Page last updated: 2024-11-02

phentermine and Feeding and Eating Disorders

phentermine has been researched along with Feeding and Eating Disorders in 3 studies

Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.

Feeding and Eating Disorders: A group of disorders characterized by physiological and psychological disturbances in appetite or food intake.

Research Excerpts

ExcerptRelevanceReference
" Phentermine-topiramate extended release may be a good therapeutic option for patients presenting with comorbid obesity and sleep-related eating disorder."8.12Phentermine-topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report. ( DeConde, J; Grunvald, E, 2022)
" Phentermine-topiramate extended release may be a good therapeutic option for patients presenting with comorbid obesity and sleep-related eating disorder."4.12Phentermine-topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report. ( DeConde, J; Grunvald, E, 2022)
"22 severe binge eaters, 17 moderate binge eaters, and 16 non-binge eaters received phentermine resin 15mg/day and dl-fenfluramine 20mg three times daily over a 6 month period for weight loss."3.70Beneficial effects of pharmacotherapy on weight loss, depressive symptoms, and eating patterns in obese binge eaters and non-binge eaters. ( Alger, SA; Cerulli, J; Fein, S; Howard, L; Malone, M, 1999)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Grunvald, E1
DeConde, J1
Alger, SA1
Malone, M1
Cerulli, J1
Fein, S1
Howard, L1
Opitz, K1

Other Studies

3 other studies available for phentermine and Feeding and Eating Disorders

ArticleYear
Phentermine-topiramate extended release for the dual treatment of obesity and sleep-related eating disorder: a case report.
    Journal of medical case reports, 2022, Jan-27, Volume: 16, Issue:1

    Topics: Adult; Anti-Obesity Agents; Feeding and Eating Disorders; Fructose; Humans; Male; Obesity; Phentermi

2022
Beneficial effects of pharmacotherapy on weight loss, depressive symptoms, and eating patterns in obese binge eaters and non-binge eaters.
    Obesity research, 1999, Volume: 7, Issue:5

    Topics: Adult; Appetite Depressants; Depression; Eating; Feeding and Eating Disorders; Female; Fenfluramine;

1999
[Anorexigenic phenylalkylamines and serotonin metabolism].
    Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1967, Volume: 259, Issue:1

    Topics: 5-Hydroxytryptophan; Animals; Appetite Depressants; Chlorphentermine; Diarrhea; Eating; Feeding and

1967